COVID-19 vaccines were made in record speed, taking around 300 days from the moment the threat was first identified. But the world’s top scientists are aiming to overtake this world record in the next pandemic, aiming to make a vaccine in 100 days.
In the COVAX Advance Market Commitment Summit, hosted by Japan, countries and industry came together to pledge support to the mission of making vaccines available equitably worldwide.
Several regulators have agreed the mRNA vaccine can be kept refrigerated for up to 30 days, making it easier to distribute in lower-resource settings.
With millions of COVID-19 vaccines now being delivered around the world, they are utilising a huge hidden infrastructure, built up over decades and spreading across the globe, with one ultimate goal: keeping the vaccines cool. How did these vaccine “cold chains” evolve, and why are they so important?
New waves of the COVID-19 pandemic in countries, such as Kenya and India, have exposed the poor management of oxygen supplies. Moina Spooner, from The Conversation Africa, asked Professor Trevor Duke, an expert on [oxygen provision] and editor of the World Health Organisation (WHO) guidelines on oxygen therapy for children, to provide insights into what countries, with limited resources, can do to secure better supplies.
As COVAX vaccines reach the rural Batsumber in Mongolia, livestock herders hope that the loneliness of the pandemic era will soon come to an end.
The UBS Optimus Foundation has launched a campaign to help secure funding for the COVAX Advance Market Commitment. Vaccines Work spoke to Tom Hall, the UBS Head of Philanthropy Services to find out why.
With tourism hit hard by the pandemic, camel riders in Northern Kenya have repurposed their herds to help spread the word about COVID-19 vaccines, using traditional healers to gain trust in the community.
In an unprecedented show of global solidarity, the world came together to back COVAX, a unique global solution aimed at making equitable access to COVID-19 vaccines possible.